Industry Research Reports

Home > Reports > Medical Devices & Consumables > Antibody Production - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Antibody Production - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-24

Pages: 104 Pages

Report ld: 2336940

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Antibody Production was estimated to be worth US$ 8847.9 million in 2023 and is forecast to a readjusted size of US$ 14630 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
North American market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Antibody Production Market Size

M= millions and B=billions

Asia-Pacific market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Antibody Production include Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody Production, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antibody Production by region & country, by Type, and by Application.

The Antibody Production market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Production.

Market Segmentation

Report Metric
Details
Report Title
Antibody Production - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 14630 million
CAGR(2024-2030)
7%
Market Size Available for Years
2019-2030
Global Antibody Production Companies Covered
Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG, FiberCell Systems Inc.
Global Antibody Production Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibody Production Market, Segment by Type
Polyclonal antibody

Monoclonal antibody

Murine

Chimeric

Humanized
Global Antibody Production Market, Segment by Application
Pharmaceutical and biotechnology companies

Research laboratories

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antibody Production manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antibody Production in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antibody Production in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Antibody Production Product Introduction
    1.2 Global Antibody Production Market Size Forecast
        1.2.1 Global Antibody Production Sales Value (2019-2030)
        1.2.2 Global Antibody Production Sales Volume (2019-2030)
        1.2.3 Global Antibody Production Sales Price (2019-2030)
    1.3 Antibody Production Market Trends & Drivers
        1.3.1 Antibody Production Industry Trends
        1.3.2 Antibody Production Market Drivers & Opportunity
        1.3.3 Antibody Production Market Challenges
        1.3.4 Antibody Production Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Antibody Production Players Revenue Ranking (2023)
    2.2 Global Antibody Production Revenue by Company (2019-2024)
    2.3 Global Antibody Production Players Sales Volume Ranking (2023)
    2.4 Global Antibody Production Sales Volume by Company Players (2019-2024)
    2.5 Global Antibody Production Average Price by Company (2019-2024)
    2.6 Key Manufacturers Antibody Production Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Antibody Production Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Antibody Production
    2.9 Antibody Production Market Competitive Analysis
        2.9.1 Antibody Production Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Antibody Production Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Production as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Polyclonal antibody
        3.1.2 Monoclonal antibody
        3.1.3 Murine
        3.1.4 Chimeric
        3.1.5 Humanized
    3.2 Global Antibody Production Sales Value by Type
        3.2.1 Global Antibody Production Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Antibody Production Sales Value, by Type (2019-2030)
        3.2.3 Global Antibody Production Sales Value, by Type (%) (2019-2030)
    3.3 Global Antibody Production Sales Volume by Type
        3.3.1 Global Antibody Production Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Antibody Production Sales Volume, by Type (2019-2030)
        3.3.3 Global Antibody Production Sales Volume, by Type (%) (2019-2030)
    3.4 Global Antibody Production Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Pharmaceutical and biotechnology companies
        4.1.2 Research laboratories
        4.1.3 Others
    4.2 Global Antibody Production Sales Value by Application
        4.2.1 Global Antibody Production Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Antibody Production Sales Value, by Application (2019-2030)
        4.2.3 Global Antibody Production Sales Value, by Application (%) (2019-2030)
    4.3 Global Antibody Production Sales Volume by Application
        4.3.1 Global Antibody Production Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Antibody Production Sales Volume, by Application (2019-2030)
        4.3.3 Global Antibody Production Sales Volume, by Application (%) (2019-2030)
    4.4 Global Antibody Production Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Antibody Production Sales Value by Region
        5.1.1 Global Antibody Production Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Antibody Production Sales Value by Region (2019-2024)
        5.1.3 Global Antibody Production Sales Value by Region (2025-2030)
        5.1.4 Global Antibody Production Sales Value by Region (%), (2019-2030)
    5.2 Global Antibody Production Sales Volume by Region
        5.2.1 Global Antibody Production Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Antibody Production Sales Volume by Region (2019-2024)
        5.2.3 Global Antibody Production Sales Volume by Region (2025-2030)
        5.2.4 Global Antibody Production Sales Volume by Region (%), (2019-2030)
    5.3 Global Antibody Production Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Antibody Production Sales Value, 2019-2030
        5.4.2 North America Antibody Production Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Antibody Production Sales Value, 2019-2030
        5.5.2 Europe Antibody Production Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Antibody Production Sales Value, 2019-2030
        5.6.2 Asia Pacific Antibody Production Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Antibody Production Sales Value, 2019-2030
        5.7.2 South America Antibody Production Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Antibody Production Sales Value, 2019-2030
        5.8.2 Middle East & Africa Antibody Production Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Antibody Production Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Antibody Production Sales Value
        6.2.1 Key Countries/Regions Antibody Production Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Antibody Production Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Antibody Production Sales Value, 2019-2030
        6.3.2 United States Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Antibody Production Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Antibody Production Sales Value, 2019-2030
        6.4.2 Europe Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Antibody Production Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Antibody Production Sales Value, 2019-2030
        6.5.2 China Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Antibody Production Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Antibody Production Sales Value, 2019-2030
        6.6.2 Japan Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Antibody Production Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Antibody Production Sales Value, 2019-2030
        6.7.2 South Korea Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Antibody Production Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Antibody Production Sales Value, 2019-2030
        6.8.2 Southeast Asia Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Antibody Production Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Antibody Production Sales Value, 2019-2030
        6.9.2 India Antibody Production Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Antibody Production Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Thermo Fisher Scientific, Inc.
        7.1.1 Thermo Fisher Scientific, Inc. Company Information
        7.1.2 Thermo Fisher Scientific, Inc. Introduction and Business Overview
        7.1.3 Thermo Fisher Scientific, Inc. Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Thermo Fisher Scientific, Inc. Antibody Production Product Offerings
        7.1.5 Thermo Fisher Scientific, Inc. Recent Development
    7.2 GE Healthcare
        7.2.1 GE Healthcare Company Information
        7.2.2 GE Healthcare Introduction and Business Overview
        7.2.3 GE Healthcare Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 GE Healthcare Antibody Production Product Offerings
        7.2.5 GE Healthcare Recent Development
    7.3 Sartorius AG
        7.3.1 Sartorius AG Company Information
        7.3.2 Sartorius AG Introduction and Business Overview
        7.3.3 Sartorius AG Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Sartorius AG Antibody Production Product Offerings
        7.3.5 Sartorius AG Recent Development
    7.4 Merck KGaA
        7.4.1 Merck KGaA Company Information
        7.4.2 Merck KGaA Introduction and Business Overview
        7.4.3 Merck KGaA Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Merck KGaA Antibody Production Product Offerings
        7.4.5 Merck KGaA Recent Development
    7.5 Eppendorf AG
        7.5.1 Eppendorf AG Company Information
        7.5.2 Eppendorf AG Introduction and Business Overview
        7.5.3 Eppendorf AG Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Eppendorf AG Antibody Production Product Offerings
        7.5.5 Eppendorf AG Recent Development
    7.6 Cellab GmbH
        7.6.1 Cellab GmbH Company Information
        7.6.2 Cellab GmbH Introduction and Business Overview
        7.6.3 Cellab GmbH Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Cellab GmbH Antibody Production Product Offerings
        7.6.5 Cellab GmbH Recent Development
    7.7 Pall Corp.
        7.7.1 Pall Corp. Company Information
        7.7.2 Pall Corp. Introduction and Business Overview
        7.7.3 Pall Corp. Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Pall Corp. Antibody Production Product Offerings
        7.7.5 Pall Corp. Recent Development
    7.8 INTEGRA Biosciences AG
        7.8.1 INTEGRA Biosciences AG Company Information
        7.8.2 INTEGRA Biosciences AG Introduction and Business Overview
        7.8.3 INTEGRA Biosciences AG Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 INTEGRA Biosciences AG Antibody Production Product Offerings
        7.8.5 INTEGRA Biosciences AG Recent Development
    7.9 FiberCell Systems Inc.
        7.9.1 FiberCell Systems Inc. Company Information
        7.9.2 FiberCell Systems Inc. Introduction and Business Overview
        7.9.3 FiberCell Systems Inc. Antibody Production Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 FiberCell Systems Inc. Antibody Production Product Offerings
        7.9.5 FiberCell Systems Inc. Recent Development

 8 Industry Chain Analysis
    8.1 Antibody Production Industrial Chain
    8.2 Antibody Production Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Antibody Production Sales Model
        8.5.2 Sales Channel
        8.5.3 Antibody Production Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Antibody Production Market Trends
    Table 2. Antibody Production Market Drivers & Opportunity
    Table 3. Antibody Production Market Challenges
    Table 4. Antibody Production Market Restraints
    Table 5. Global Antibody Production Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antibody Production Revenue Market Share by Company (2019-2024)
    Table 7. Global Antibody Production Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Antibody Production Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Antibody Production Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Antibody Production Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Antibody Production Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Antibody Production
    Table 13. Global Antibody Production Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Production as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antibody Production Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Antibody Production Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Antibody Production Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Antibody Production Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Antibody Production Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Antibody Production Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Antibody Production Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Antibody Production Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Antibody Production Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Antibody Production Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Antibody Production Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Antibody Production Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Antibody Production Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Antibody Production Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Antibody Production Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Antibody Production Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Antibody Production Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Antibody Production Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Antibody Production Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Antibody Production Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Antibody Production Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Antibody Production Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Antibody Production Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Antibody Production Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Antibody Production Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Antibody Production Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Antibody Production Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Antibody Production Sales Value by Region (2019-2024) & (%)
    Table 44. Global Antibody Production Sales Value by Region (2025-2030) & (%)
    Table 45. Global Antibody Production Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Antibody Production Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Antibody Production Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Antibody Production Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Antibody Production Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Antibody Production Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Antibody Production Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Antibody Production Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Antibody Production Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Antibody Production Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Antibody Production Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Antibody Production Sales Volume, (2025-2030) & (K MT)
    Table 57. Thermo Fisher Scientific, Inc. Company Information
    Table 58. Thermo Fisher Scientific, Inc. Introduction and Business Overview
    Table 59. Thermo Fisher Scientific, Inc. Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. Thermo Fisher Scientific, Inc. Antibody Production Product Offerings
    Table 61. Thermo Fisher Scientific, Inc. Recent Development
    Table 62. GE Healthcare Company Information
    Table 63. GE Healthcare Introduction and Business Overview
    Table 64. GE Healthcare Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. GE Healthcare Antibody Production Product Offerings
    Table 66. GE Healthcare Recent Development
    Table 67. Sartorius AG Company Information
    Table 68. Sartorius AG Introduction and Business Overview
    Table 69. Sartorius AG Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Sartorius AG Antibody Production Product Offerings
    Table 71. Sartorius AG Recent Development
    Table 72. Merck KGaA Company Information
    Table 73. Merck KGaA Introduction and Business Overview
    Table 74. Merck KGaA Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Merck KGaA Antibody Production Product Offerings
    Table 76. Merck KGaA Recent Development
    Table 77. Eppendorf AG Company Information
    Table 78. Eppendorf AG Introduction and Business Overview
    Table 79. Eppendorf AG Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Eppendorf AG Antibody Production Product Offerings
    Table 81. Eppendorf AG Recent Development
    Table 82. Cellab GmbH Company Information
    Table 83. Cellab GmbH Introduction and Business Overview
    Table 84. Cellab GmbH Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Cellab GmbH Antibody Production Product Offerings
    Table 86. Cellab GmbH Recent Development
    Table 87. Pall Corp. Company Information
    Table 88. Pall Corp. Introduction and Business Overview
    Table 89. Pall Corp. Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Pall Corp. Antibody Production Product Offerings
    Table 91. Pall Corp. Recent Development
    Table 92. INTEGRA Biosciences AG Company Information
    Table 93. INTEGRA Biosciences AG Introduction and Business Overview
    Table 94. INTEGRA Biosciences AG Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. INTEGRA Biosciences AG Antibody Production Product Offerings
    Table 96. INTEGRA Biosciences AG Recent Development
    Table 97. FiberCell Systems Inc. Company Information
    Table 98. FiberCell Systems Inc. Introduction and Business Overview
    Table 99. FiberCell Systems Inc. Antibody Production Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. FiberCell Systems Inc. Antibody Production Product Offerings
    Table 101. FiberCell Systems Inc. Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Antibody Production Downstream Customers
    Table 105. Antibody Production Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibody Production Product Picture
    Figure 2. Global Antibody Production Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Antibody Production Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Antibody Production Sales Price (2019-2030) & (USD/MT)
    Figure 6. Antibody Production Report Years Considered
    Figure 7. Global Antibody Production Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Antibody Production Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antibody Production Revenue in 2023
    Figure 10. Antibody Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Polyclonal antibody Picture
    Figure 12. Monoclonal antibody Picture
    Figure 13. Murine Picture
    Figure 14. Chimeric Picture
    Figure 15. Humanized Picture
    Figure 16. Global Antibody Production Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Antibody Production Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Antibody Production Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 19. Global Antibody Production Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Antibody Production Price by Type (2019-2030) & (USD/MT)
    Figure 21. Product Picture of Pharmaceutical and biotechnology companies
    Figure 22. Product Picture of Research laboratories
    Figure 23. Product Picture of Others
    Figure 24. Global Antibody Production Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Antibody Production Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Antibody Production Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 27. Global Antibody Production Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Antibody Production Price by Application (2019-2030) & (USD/MT)
    Figure 29. North America Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Antibody Production Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Antibody Production Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Antibody Production Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Antibody Production Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Antibody Production Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Antibody Production Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Antibody Production Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Antibody Production Sales Volume (%), (2019-2030)
    Figure 41. United States Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Antibody Production Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Antibody Production Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Antibody Production Sales Value by Application (%), 2023 VS 2030
    Figure 62. Antibody Production Industrial Chain
    Figure 63. Antibody Production Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Description

The global market for Antibody Production was estimated to be worth US$ 8847.9 million in 2023 and is forecast to a readjusted size of US$ 14630 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030
North American market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Antibody Production was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Antibody Production include Thermo Fisher Scientific, Inc., GE Healthcare, Sartorius AG, Merck KGaA, Eppendorf AG, Cellab GmbH, Pall Corp., INTEGRA Biosciences AG and FiberCell Systems Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antibody Production, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antibody Production by region & country, by Type, and by Application.

The Antibody Production market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Production.

Market Segmentation